top of page

OOTR Co-organised the 16th Asia Pacific Multidisciplinary Meeting for Cancer Research - CANCER 2024

Together with the Chinese University of Hong Kong (CUHK) and the International Academy of Pathology Hong Kong Division, OOTR has successfully co-organised the 16th Asia Pacific Multidisciplinary Meeting for Cancer Research – CANCER 2024 in Hong Kong.


The theme of the conference was "Cancer Immunotherapy" and speakers from Hong Kong, Singapore, Germany, and the UK delivered engaging presentations and discussions on topics such as CAR-T, AI-guided drug discovery, and the use of immunotherapy in solid tumors like lung and breast cancer.


More details are available on the CUHK website: https://www.cuhk.edu.hk/med/acp/cancer2024/index.html.


OOTR-N016 Exploratory Analyses Presented at SABCS 2024

The exploratory analysis results for the OOTR-N016/KBCRN-B-003/PAB-HT trial (NCT03969121) were presented at the 2024 San Antonio Breast Cancer Symposium.


The poster title is: "Subtype by PAM50 Changes After Neoadjuvant Endocrine Therapy: A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy Plus Palbociclib versus Hormonal Therapy Plus Placebo in Women with Operable, Hormone-Sensitive, and HER2-Negative Primary Breast Cancer" (poster ID: P5-04-28).

This poster presented the exploratory analysis results conducted on the OOTR-N016 trial to understand the biological changes following endocrine therapy (ET), predict the efficacy of ET, and consider potential additional therapies.


23

© 2025 by the Organisation for Oncology and Translational Research (OOTR)

bottom of page